Pinnacle Wealth Planning Services, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Pinnacle Wealth Planning Services, Inc.
- $733 Million
- Q3 2024
A detailed history of Pinnacle Wealth Planning Services, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Pinnacle Wealth Planning Services, Inc. holds 612 shares of REGN stock, worth $473,076. This represents 0.09% of its overall portfolio holdings.
Number of Shares
612
Previous 612
-0.0%
Holding current value
$473,076
Previous $643,000
-0.0%
% of portfolio
0.09%
Previous 0.09%
Shares
14 transactions
Others Institutions Holding REGN
# of Institutions
1,534Shares Held
83.8MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$7.2 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.53 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.79 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.79 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.32 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $82.9B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...